Singapore markets closed

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
108.35-3.25 (-2.91%)
At close: 03:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 174.80B
Enterprise value 199.44B
Trailing P/E N/A
Forward P/E 13.81
PEG Ratio (5 yr expected) 1.16
Price/sales (ttm)3.81
Price/book (mrq)4.67
Enterprise value/revenue 4.53
Enterprise value/EBITDA 28.08

Trading information

Stock price history

Beta (5Y monthly) 0.13
52-week change 3-11.41%
S&P500 52-week change 3-16.88%
52-week high 3143.90
52-week low 3105.26
50-day moving average 3125.79
200-day moving average 3123.97

Share statistics

Avg vol (3-month) 32.27k
Avg vol (10-day) 32.95k
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.54B
% held by insiders 10.21%
% held by institutions 149.36%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.8
Forward annual dividend yield 42.59%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 32.60%
5-year average dividend yield 43.04
Payout ratio 4N/A
Dividend date 308 Sept 2019
Ex-dividend date 410 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin -2.85%
Operating margin (ttm)17.08%

Management effectiveness

Return on assets (ttm)5.52%
Return on equity (ttm)-4.84%

Income statement

Revenue (ttm)44.04B
Revenue per share (ttm)28.67
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)27.61B
EBITDA 12.52B
Net income avi to common (ttm)-1.25B
Diluted EPS (ttm)-0.72
Quarterly earnings growth (yoy)-34.50%

Balance sheet

Total cash (mrq)4.89B
Total cash per share (mrq)3.15
Total debt (mrq)31.39B
Total debt/equity (mrq)87.31
Current ratio (mrq)0.96
Book value per share (mrq)23.20

Cash flow statement

Operating cash flow (ttm)7.62B
Levered free cash flow (ttm)3.99B